Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

STERIS Corp (NYSE:STE)

68.69
Delayed Data
As of Jul 30
 +0.08 / +0.12%
Today’s Change
49.78
Today|||52-Week Range
71.39
+5.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$4.1B

Company Description

STERIS Corp. engages in the provision of infection prevention and other procedural products & services, focused on healthcare, pharmaceutical, and research industries. It operates through three segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. The Life Sciences segment serves segment manufactures and sells a broad range of capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies and private and public research facilities around the globe. The STERIS Isomedix Services segment provides ethylene oxide and irradiation services on a contract basis through a network of facilities in North America. The company was founded by Raymond C. Kralovic and Edward T. Schneider in August 9, 1985 and is headquartered in Mentor, OH.

Contact Information

STERIS Corp.
5960 Heisley Road
Mentor Ohio 44060-1834
P:(440) 354-2600
Investor Relations:
(440) 392-7245

Employees

Shareholders

Mutual fund holders62.38%
Other institutional47.18%
Individual stakeholders2.26%

Top Executives

Walter M. RosebroughPresident, Chief Executive Officer & Director
Michael J. TokichChief Financial Officer, Treasurer & Senior VP
Peter A. BurkeChief Technology Officer & Senior Vice President
Kathleen Lynn BardwellChief Compliance Officer & Senior Vice President
Robert E. MossGroup President-Isomedix Services & Senior VP